LGLSX
Price
$54.51
Change
+$0.14 (+0.26%)
Updated
Dec 3 closing price
Net Assets
7.83B
RGEBX
Price
$85.45
Change
+$0.51 (+0.60%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

LGLSX vs RGEBX

Header iconLGLSX vs RGEBX Comparison
Open Charts LGLSX vs RGEBXBanner chart's image
Lord Abbett Growth Leaders R4
Price$54.51
Change+$0.14 (+0.26%)
VolumeN/A
Net Assets7.83B
American Funds Growth Fund of Amer R2E
Price$85.45
Change+$0.51 (+0.60%)
VolumeN/A
Net Assets338.91B
LGLSX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
LGLSX vs. RGEBX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLSX is a StrongBuy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 339B vs. LGLSX (7.83B). LGLSX (0.00) and RGEBX (0.00) have matching dividends . LGLSX was incepted earlier than RGEBX: LGLSX (10 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LGLSX (0.90). LGLSX is a more actively managed with annual turnover of: 94.00 vs. RGEBX (25.00). LGLSX has a lower initial minimum investment than RGEBX: LGLSX (0) vs RGEBX (250). LGLSX annual gain was more profitable for investors over the last year : 15.06 vs. RGEBX (6.24). RGEBX (28.63) and LGLSX (27.93) have equivalent 5 years return.
LGLSXRGEBXLGLSX / RGEBX
Total Expense Ratio0.901.0983%
Annual Report Gross Expense Ratio0.901.0983%
Fund Existence10 years11 years-
Gain YTD16.88518.39392%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.83B339B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.066.24241%
Returns for 3 years104.2959.18176%
Returns for 5 years27.9328.6398%
Returns for 10 years140.4985.53164%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDIAX56.63N/A
N/A
Janus Henderson Overseas A
RYOAX67.38N/A
N/A
Rydex Biotechnology H
MUOIX34.37N/A
N/A
Morgan Stanley Instl US Core I
GSEPX75.53N/A
N/A
Goldman Sachs US Equity Insights P
FMCMX48.29N/A
N/A
American Funds AMCAP 529-F-3